The influence of liver transplantation on the interplay between gut microbiome and bile acid homeostasis in children with biliary atresiaOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
Researchers examined how liver transplantation affects the gut microbiome and bile acid balance in children with biliary atresia. Patients were sampled before transplant and at three months, twelve months, and more than twenty four months after.
How was it studied?
The team used 16S rRNA sequencing to profile the intestinal microbiome in four groups (pre transplant n=10, 3 months n=12, 12 months n=9, 24+ months n=12). They also measured serum primary and secondary bile acid levels and linked microbial genera to immunosuppressant use.
What did they find?
Alpha diversity was markedly reduced before transplant (p=0.015) and at 3 months (p=0.044), then approximated healthy controls by 12 months (p=1.0) and 24+ months (p=0.74). Klebsiella abundance was higher than age matched controls at 24+ months (p=0.029), and secondary bile acid production increased at that same late timepoint (p=0.03). Several microbial genera correlated with tacrolimus and mycophenolate mofetil regimens.
Why it matters
The findings suggest gut microbiome recovery after liver transplant in biliary atresia tracks with restored bile flow and secondary bile acid synthesis, while also being shaped by which immunosuppressants a child receives.